15120577 30606244 12052539 24646874 12895444 11816796 30337026 26833257 19699201 12052177 16246054 23773066 14501012 17986151 12453676 11771748 12423367 35089425 12374855 22911757 17076261 16804637 15541434 14600149 16908986 12142279 12495166 3161507 - Search Results

Year	Number of Results
2000	4
2001	26
2002	37
2003	25
2004	19
2005	16
2006	25
2007	13
2008	13
2009	14
2010	21
2011	12
2012	21
2013	11
2014	13
2015	5
2016	10
2017	10
2018	14
2019	11
2020	5
2021	8
2022	8
2023	1

1

Increased beta-secretase activity and expression in rats following transient cerebral ischemia.

Wen Y, Onyewuchi O, Yang S, Liu R, Simpkins JW. Wen Y, et al. Brain Res. 2004 May 29;1009(1-2):1-8. doi: 10.1016/j.brainres.2003.09.086. Brain Res. 2004. PMID: 15120577

2

Matriptase cleaves the amyloid-beta peptide 1-42 at Arg-5, Lys-16, and Lys-28.

Chen LM, Chai KX. Chen LM, et al. BMC Res Notes. 2019 Jan 3;12(1):5. doi: 10.1186/s13104-018-4040-z. BMC Res Notes. 2019. PMID: 30606244 Free PMC article.

3

Elevated expression of beta-site amyloid precursor protein cleaving enzyme 2 in brains of patients with Down syndrome.

Motonaga K, Itoh M, Becker LE, Goto Y, Takashima S. Motonaga K, et al. Neurosci Lett. 2002 Jun 21;326(1):64-6. doi: 10.1016/s0304-3940(02)00287-2. Neurosci Lett. 2002. PMID: 12052539

4

Current concepts and clinical applications of stroke genetics.

Falcone GJ, Malik R, Dichgans M, Rosand J. Falcone GJ, et al. Lancet Neurol. 2014 Apr;13(4):405-18. doi: 10.1016/S1474-4422(14)70029-8. Lancet Neurol. 2014. PMID: 24646874 Review.

5

BACE-2 is overexpressed in Down's syndrome.

Barbiero L, Benussi L, Ghidoni R, Alberici A, Russo C, Schettini G, Pagano SF, Parati EA, Mazzoli F, Nicosia F, Signorini S, Feudatari E, Binetti G. Barbiero L, et al. Exp Neurol. 2003 Aug;182(2):335-45. doi: 10.1016/s0014-4886(03)00049-9. Exp Neurol. 2003. PMID: 12895444

6

Genetically engineered models relevant to neurodegenerative disorders: their value for understanding disease mechanisms and designing/testing experimental therapeutics.

Wong PC, Cai H, Borchelt DR, Price DL. Wong PC, et al. J Mol Neurosci. 2001 Oct;17(2):233-57. doi: 10.1385/JMN:17:2:233. J Mol Neurosci. 2001. PMID: 11816796 Review.

7

Vitis vinifera acts as anti-Alzheimer's agent by modulating biochemical parameters implicated in cognition and memory.

Rapaka D, Bitra VR, Vishala TC, Akula A. Rapaka D, et al. J Ayurveda Integr Med. 2019 Oct-Dec;10(4):241-247. doi: 10.1016/j.jaim.2017.06.013. Epub 2018 Oct 15. J Ayurveda Integr Med. 2019. PMID: 30337026 Free PMC article.

8

BACE1 Physiological Functions May Limit Its Use as Therapeutic Target for Alzheimer's Disease.

Barão S, Moechars D, Lichtenthaler SF, De Strooper B. Barão S, et al. Trends Neurosci. 2016 Mar;39(3):158-169. doi: 10.1016/j.tins.2016.01.003. Epub 2016 Jan 30. Trends Neurosci. 2016. PMID: 26833257 Review.

9

Neurogenesis and Alzheimer's disease: at the crossroads.

Lazarov O, Marr RA. Lazarov O, et al. Exp Neurol. 2010 Jun;223(2):267-81. doi: 10.1016/j.expneurol.2009.08.009. Epub 2009 Aug 19. Exp Neurol. 2010. PMID: 19699201 Free PMC article. Review.

10

Beta-secretase as a therapeutic target for inhibitor drugs.

Ghosh AK, Hong L, Tang J. Ghosh AK, et al. Curr Med Chem. 2002 Jun;9(11):1135-44. doi: 10.2174/0929867023370149. Curr Med Chem. 2002. PMID: 12052177 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results